Friendsgiving

A year of tirzepatide

See how
Belle Cares

We're giving $50,000.

Nominate
safety information
Compounded • Not FDA-evaluated

Important Safety Information

MOTS-c

MOTS-c is a peptide encoded in mitochondrial DNA, studied for its role in metabolism. It is offered here as an elective wellness treatment.

At Belle, MOTS-c is offered in compounded injectable form, prescribed when deemed clinically appropriate by a licensed healthcare provider. Please review the following important safety information before beginning treatment.

What Is MOTS-c?

MOTS-c therapy is considered an elective wellness treatment. The compounded medication has not been evaluated or approved by the FDA for safety or effectiveness, and has not been evaluated for anti-aging or general wellness purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

Human safety and effectiveness data for MOTS-c are limited. Long-term effects are not established.

Always consult your healthcare provider before beginning any injectable regimen, especially if you have pre-existing health conditions.

Who Should Not Use MOTS-c

MOTS-c should not be used by individuals who:

  • Are allergic to MOTS-c or any ingredient in the formulation
  • Are pregnant, trying to become pregnant, or breastfeeding
  • Have an active cancer, or a history of cancer, without clearance from their oncology provider
  • Have uncontrolled chronic illnesses without supervision from a licensed provider

Precautions and Warnings

Inform your provider if you have or have had:

  • Diabetes or blood sugar dysregulation
  • Use of glucose-lowering medication
  • Kidney or liver disease
  • Cardiovascular disease
  • History of cancer

Common Side Effects

Side effects associated with MOTS-c may include:

  • Injection site redness, swelling, or discomfort
  • Headache
  • Fatigue
  • Nausea
  • Lightheadedness

If you experience any severe or prolonged symptoms, notify your provider immediately.

Serious Reactions (Rare)

In rare cases, patients may experience:

  • Hypersensitivity or allergic reaction
  • Signs of infection at the injection site (spreading redness, warmth, pus, or fever)
  • Worsening of pre-existing conditions

Stop treatment and seek medical attention immediately if you experience trouble breathing, chest pain, or swelling of the face, lips, or throat.

Use and Administration

  • Use MOTS-c only as directed by your licensed provider.
  • Do not exceed the prescribed dosage or frequency.
  • MOTS-c is typically administered via subcutaneous injection unless your provider directs otherwise.
  • If you miss a dose, contact your provider for guidance before resuming.
  • Report any adverse effects or unexpected symptoms during treatment.

Storage and Disposal

Store MOTS-c as directed on the pharmacy label, typically refrigerated and protected from light. Do not use expired products. Dispose of needles in a sharps container. Keep out of reach of children.

For informational purposes only. Not a substitute for medical advice, diagnosis, or treatment. Consult a licensed provider. In emergencies, call 911.